REGENXBIO Inc.
Status: Publicly traded
Direct answer
REGENXBIO Inc. is publicly traded on NASDAQ under the ticker RGNX.
REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an...
Can you invest in REGENXBIO Inc.?
Yes. REGENXBIO Inc. is publicly traded on NASDAQ under the ticker RGNX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for REGENXBIO Inc.
Detailed equity research is provided by MarketSnap.